Merozoite Surface Protein 1
"Merozoite Surface Protein 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A surface protein found on Plasmodium species which induces a T-cell response. The antigen is polymorphic, sharing amino acid sequence homology among PLASMODIUM FALCIPARUM; PLASMODIUM CHABAUDI; PLASMODIUM VIVAX; and PLASMODIUM YOELII.
| Descriptor ID |
D020066
|
| MeSH Number(s) |
D12.776.820.500 D23.050.293.500
|
| Concept/Terms |
Merozoite Surface Protein 1- Merozoite Surface Protein 1
- MSA-1 Protein
- MSA 1 Protein
- Protein, MSA-1
- MSP-1
- Plasmodium falciparum Merozoite Precursor Surface Coat Protein
- Major Merozoite Surface Protein Precursor
- Merozoite Surface Protein-1
- Surface Protein-1, Merozoite
- MSA1
- MSA1 Protein
- Protein, MSA1
- PFM-PSCP
- PMMSA
- MSP1
- MSA-1
- Merozoite Surface Antigen 1
|
Below are MeSH descriptors whose meaning is more general than "Merozoite Surface Protein 1".
Below are MeSH descriptors whose meaning is more specific than "Merozoite Surface Protein 1".
This graph shows the total number of publications written about "Merozoite Surface Protein 1" by people in this website by year, and whether "Merozoite Surface Protein 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Merozoite Surface Protein 1" by people in Profiles.
-
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial. Neurology. 2023 07 18; 101(3):e238-e252.
-
Protective Immunity in Mice Immunized With P. vivax MSP119-Based Formulations and Challenged With P. berghei Expressing PvMSP119. Front Immunol. 2020; 11:28.
-
A longitudinal cohort study of malaria exposure and changing serostatus in a malaria endemic area of rural Tanzania. Malar J. 2017 08 02; 16(1):309.
-
Differing patterns of selection and geospatial genetic diversity within two leading Plasmodium vivax candidate vaccine antigens. PLoS Negl Trop Dis. 2014 Apr; 8(4):e2796.
-
Plasmodium falciparum malaria in the Peruvian Amazon, a region of low transmission, is associated with immunologic memory. Infect Immun. 2012 Apr; 80(4):1583-92.
-
The Plasmodium falciparum merozoite surface protein-1 19 KD antibody response in the Peruvian Amazon predominantly targets the non-allele specific, shared sites of this antigen. Malar J. 2010 Jan 04; 9:3.
-
Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission. Malar J. 2008 Sep 09; 7:173.
-
Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women. Infect Immun. 2004 Mar; 72(3):1603-7.
-
Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malaria. Infect Immun. 2002 Mar; 70(3):1417-21.
-
Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid. Vaccine. 1999 Oct 14; 18(5-6):531-9.